Cassava Sciences Inc (SAVA)

[sokol]

The filer that filed the Citizen Petition to pause SAVA’s clinical trials is a N.Y. law firm.

https://www.labaton.com/ourpeople-attorneys

Download and take a look at these two documents filed with the FDA:

https://downloads.regulations.gov/FDA-2021-P-0930-0003/content.pdf

https://downloads.regulations.gov/FDA-2021-P-0930-0004/content.pdf

It’s a definite problem for SAVA. It will take quite some time to know the out come. No matter how one may try to sugar coat it, it is not good news.

Shareholders have had high hopes for simufilam’s quick development and approval. This Citizen Petition has cast a cloud over SAVA and how it has gone about developing and promoting simufilam.

SAVA’s negative news is affecting other biotechs that are in competition with SAVA, but the claims/allegations in this Petition have nothing to do with other biotechs that are developing Alzheimer’s drugs.